Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal pigment epithelial cell | 3 studies | 26% ± 8% |
Insufficient scRNA-seq data for expression of SLC45A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 75% | 36.38 | 1360 / 1809 | 90% | 154.99 | 427 / 472 |
prostate | 75% | 15.42 | 184 / 245 | 69% | 9.02 | 344 / 502 |
liver | 96% | 67.91 | 217 / 226 | 22% | 0.82 | 89 / 406 |
kidney | 94% | 45.25 | 84 / 89 | 20% | 0.77 | 183 / 901 |
eye | 0% | 0 | 0 / 0 | 100% | 83.00 | 80 / 80 |
brain | 92% | 20.86 | 2427 / 2642 | 3% | 0.05 | 21 / 705 |
stomach | 67% | 21.85 | 241 / 359 | 3% | 0.13 | 10 / 286 |
adrenal gland | 55% | 10.59 | 142 / 258 | 14% | 0.26 | 32 / 230 |
muscle | 66% | 9.68 | 529 / 803 | 0% | 0 | 0 / 0 |
heart | 61% | 14.26 | 523 / 861 | 0% | 0 | 0 / 0 |
lung | 52% | 5.41 | 298 / 578 | 4% | 0.08 | 42 / 1155 |
intestine | 48% | 10.88 | 465 / 966 | 3% | 0.06 | 18 / 527 |
pancreas | 42% | 3.98 | 138 / 328 | 4% | 0.14 | 7 / 178 |
breast | 43% | 7.26 | 196 / 459 | 2% | 0.05 | 20 / 1118 |
bladder | 38% | 2.95 | 8 / 21 | 6% | 0.14 | 30 / 504 |
thymus | 37% | 3.04 | 239 / 653 | 4% | 0.12 | 24 / 605 |
spleen | 40% | 4.10 | 96 / 241 | 0% | 0 | 0 / 0 |
uterus | 30% | 3.41 | 51 / 170 | 3% | 0.38 | 14 / 459 |
ovary | 28% | 2.36 | 51 / 180 | 0% | 0.00 | 1 / 430 |
peripheral blood | 26% | 4.20 | 237 / 929 | 0% | 0 | 0 / 0 |
adipose | 23% | 2.21 | 280 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 22% | 1.86 | 294 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 18% | 1.43 | 265 / 1445 | 3% | 0.09 | 6 / 183 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0048066 | Biological process | developmental pigmentation |
GO_0015770 | Biological process | sucrose transport |
GO_1904659 | Biological process | glucose transmembrane transport |
GO_0006583 | Biological process | melanin biosynthetic process from tyrosine |
GO_0035752 | Biological process | lysosomal lumen pH elevation |
GO_0033162 | Cellular component | melanosome membrane |
GO_0016020 | Cellular component | membrane |
GO_0008506 | Molecular function | sucrose:proton symporter activity |
GO_0005356 | Molecular function | glucose:proton symporter activity |
Gene name | SLC45A2 |
Protein name | Solute carrier family 45 member 2 Membrane-associated transporter protein SLC45A2 Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Solute carrier family 45 member 2) SLC45A2 (Solute carrier family 45, member 2, isoform CRA_a) |
Synonyms | AIM1 MATP hCG_37411 |
Description | FUNCTION: Proton-associated glucose and sucrose transporter (By similarity). May be able to transport also fructose (By similarity). Expressed at a late melanosome maturation stage where functions as proton/glucose exporter which increase lumenal pH by decreasing glycolysis . Regulates melanogenesis by maintaining melanosome neutralization that is initially initiated by transient OCA2 and required for a proper function of the tyrosinase TYR . . |
Accessions | Q9UMX9 ENST00000631273.1 D6RGY6 D6RBP8 ENST00000626332.2 ENST00000296589.9 [Q9UMX9-1] ENST00000510600.1 A0A0G2JQI6 ENST00000631255.2 A0A0G2JSD6 A0A076YGN1 A0A0G2JQN1 ENST00000509381.1 A0A0G2JSC7 A0A076YN63 ENST00000626082.1 A0A076YIB8 ENST00000382102.7 [Q9UMX9-4] |